This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: L & J Bio Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kwan Hee Lee: Innovator in Alzheimer's Disease Treatment
Introduction
Kwan Hee Lee is a notable inventor based in Las Vegas, NV (US). He has made significant contributions to the field of medical science, particularly in the treatment of Alzheimer's disease. His innovative approach focuses on addressing protein deficiencies in the central nervous system.
Latest Patents
Kwan Hee Lee holds 1 patent for his invention titled "Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein." This patent discloses a method for treating protein deficiencies by systemically administering a fusion polypeptide that effectively crosses the blood-brain barrier.
Career Highlights
Kwan Hee Lee is associated with L & J Bio Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating therapeutic solutions for neurological disorders, showcasing his commitment to improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Sookhee Bang and Jeong Kuen Song, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kwan Hee Lee's contributions to Alzheimer's disease treatment through his patented methods highlight his role as a leading inventor in the medical field. His work not only addresses critical health challenges but also paves the way for future advancements in neuroscience.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile